









Mercado
/
Acciones
/
nasdaq-cvs
/

CVS Health Corp

CVS

62.470USD

+0.370+0.60%

Cierre 08/01, 16:00（ET）Cotizaciones retrasadas 15 min

78.84BCap. mercado

14.93P/E TTM



CVS Health Corp

62.470

+0.370+0.60%

Descripción general Compañía Finanzas

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.

Información de la empresa

Símbolo de cotizaciónCVS

Nombre de la empresaCVS Health Corp

Fecha de salida a bolsaOct 01, 1952

Fundada en1996

Director ejecutivoMr. J. David Joyner

Número de empleados300000

Tipo de seguridadOrdinary Share

Fin del año fiscalOct 01

Dirección1 Cvs Dr

CiudadWOONSOCKET

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal02895-6146

Teléfono14017651500

Sitio Webhttps://cvshealth.com/

Símbolo de cotizaciónCVS

Fecha de salida a bolsaOct 01, 1952

Fundada en1996

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Larry Robbins

Independent Director

11.95M

Mr. Tilak Mandadi

Executive Vice President, Chief Data, Digital, Analytics and Technology Officer

60.01K

+48.50%

Mr. Michael F. (Mike) Mahoney

Lead Independent Director

45.91K

+0.31%

Mr. Steven H. Nelson

Executive Vice President and President - Aetna

21.33K

Mr. Guy P. Sansone

Independent Director

12.01K

+15.04%

Mr. Douglas H. (Doug) Shulman, J.D.

Independent Director

4.28K

+94.41%

Ms. Leslie V. Norwalk

Director

4.28K

+94.41%

Mr. Roger N. Farah

Executive Chairman of the Board

4.12K

-92.40%

Ms. Alecia A. DeCoudreaux, J.D.

Independent Director

2.97K

Dr. Amy L. Compton-Phillips, M.D.

Executive Vice President and Chief Medical Officer

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Larry Robbins

Independent Director

11.95M

Mr. Tilak Mandadi

Executive Vice President, Chief Data, Digital, Analytics and Technology Officer

60.01K

+48.50%

Mr. Michael F. (Mike) Mahoney

Lead Independent Director

45.91K

+0.31%

Mr. Steven H. Nelson

Executive Vice President and President - Aetna

21.33K

Mr. Guy P. Sansone

Independent Director

12.01K

+15.04%

Mr. Douglas H. (Doug) Shulman, J.D.

Independent Director

4.28K

+94.41%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

Por negocioUSD

Nombre

Ganancia

Proporción

Pharmacy

52.51B

55.51%

Premiums

32.82B

34.70%

Front Store

5.24B

5.54%

Other

3.50B

3.70%

Net investment income(loss)

520.00M

0.55%

Sin datos

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Pharmacy

52.51B

55.51%

Premiums

32.82B

34.70%

Front Store

5.24B

5.54%

Other

3.50B

3.70%

Net investment income(loss)

520.00M

0.55%

Estadísticas de accionistas

Actualizado: jue., 15 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

The Vanguard Group, Inc.

9.31%

Dodge & Cox

5.81%

Capital World Investors

5.41%

BlackRock Institutional Trust Company, N.A.

5.13%

State Street Global Advisors (US)

4.58%

Other

69.76%

Accionistas

Proporción

The Vanguard Group, Inc.

9.31%

Dodge & Cox

5.81%

Capital World Investors

5.41%

BlackRock Institutional Trust Company, N.A.

5.13%

State Street Global Advisors (US)

4.58%

Other

69.76%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

46.81%

Investment Advisor/Hedge Fund

28.45%

Hedge Fund

3.63%

Research Firm

2.87%

Pension Fund

1.98%

Bank and Trust

1.94%

Sovereign Wealth Fund

1.57%

Individual Investor

1.06%

Insurance Company

0.10%

Other

11.59%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

3683

1.12B

88.27%

+7.67M

2025Q1

3787

1.12B

88.80%

+14.13M

2024Q4

3853

1.08B

85.46%

-1.57M

2024Q3

3812

1.05B

83.30%

-34.78M

2024Q2

3834

1.06B

84.02%

-4.44M

2024Q1

3863

1.03B

82.03%

-36.45M

2023Q4

3882

1.05B

81.65%

-1.13M

2023Q3

3770

1.04B

80.61%

-13.78M

2023Q2

3775

1.03B

80.60%

-13.09M

2023Q1

3785

1.03B

80.72%

-44.48M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

The Vanguard Group, Inc.

117.73M

9.31%

+968.46K

+0.83%

Mar 31, 2025

Dodge & Cox

73.46M

5.81%

+3.35M

+4.78%

Mar 31, 2025

Capital World Investors

68.40M

5.41%

+7.36M

+12.06%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

64.96M

5.13%

+4.87M

+8.11%

Mar 31, 2025

State Street Global Advisors (US)

57.99M

4.58%

+1.04M

+1.82%

Mar 31, 2025

Geode Capital Management, L.L.C.

27.96M

2.21%

+907.87K

+3.36%

Mar 31, 2025

Capital International Investors

26.19M

2.07%

-478.74K

-1.80%

Mar 31, 2025

Fidelity Management & Research Company LLC

24.22M

1.91%

+3.08M

+14.57%

Mar 31, 2025

Capital Research Global Investors

18.73M

1.48%

+16.22M

+647.44%

Mar 31, 2025

Norges Bank Investment Management (NBIM)

18.70M

1.48%

+3.80M

+25.51%

Dec 31, 2024

ETFs relacionados

Actualizado: dom., 6 de jul

Nombre

Proporción

Davis Select US Equity ETF

5.18%

Invesco S&P Ultra Dividend Revenue ETF

4.72%

iShares U.S. Healthcare Providers ETF

4.71%

VanEck Retail ETF

4.2%

iShares US Consumer Staples ETF

3.65%

Brookstone Value Stock ETF

3.54%

Invesco S&P 500 Enhanced Value ETF

3.47%

Invesco S&P 500 Pure Value ETF

3.23%

First Trust Consumer Staples Alphadex Fund

3.23%

Leatherback Long/Short Alternative Yield ETF

3.02%

Davis Select US Equity ETF

Proporción5.18%

Invesco S&P Ultra Dividend Revenue ETF

Proporción4.72%

iShares U.S. Healthcare Providers ETF

Proporción4.71%

VanEck Retail ETF

Proporción4.2%

iShares US Consumer Staples ETF

Proporción3.65%

Brookstone Value Stock ETF

Proporción3.54%

Invesco S&P 500 Enhanced Value ETF

Proporción3.47%

Invesco S&P 500 Pure Value ETF

Proporción3.23%

First Trust Consumer Staples Alphadex Fund

Proporción3.23%

Leatherback Long/Short Alternative Yield ETF

Proporción3.02%

Dividendos

Un total de 14.66B USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Jan 03, 2025

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 03, 2025 going ex on Jan 23, 2025

Jan 23, 2025

Feb 03, 2025

Jan 23, 2025

Sep 19, 2024

CVS.NB Final Cash Dividend of gross USD 0.665 paid on Nov 01, 2024 going ex on Oct 21, 2024

Oct 21, 2024

Nov 01, 2024

Oct 21, 2024

Jul 08, 2024

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Aug 01, 2024 going ex on Jul 22, 2024

Jul 22, 2024

Aug 01, 2024

Jul 22, 2024

Mar 21, 2024

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on May 01, 2024 going ex on Apr 19, 2024

Apr 22, 2024

May 01, 2024

Apr 19, 2024

Dec 06, 2023

CVS.NB Interim Cash Dividend of gross USD 0.665 paid on Feb 01, 2024 going ex on Jan 19, 2024

Jan 22, 2024

Feb 01, 2024

Jan 19, 2024

Sep 21, 2023

CVS.NB Final Cash Dividend of gross USD 0.605 paid on Nov 01, 2023 going ex on Oct 19, 2023

Oct 20, 2023

Nov 01, 2023

Oct 19, 2023

Jul 07, 2023

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Aug 01, 2023 going ex on Jul 20, 2023

Jul 21, 2023

Aug 01, 2023

Jul 20, 2023

Mar 16, 2023

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on May 01, 2023 going ex on Apr 20, 2023

Apr 21, 2023

May 01, 2023

Apr 20, 2023

Dec 15, 2022

CVS.NB Interim Cash Dividend of gross USD 0.605 paid on Feb 01, 2023 going ex on Jan 19, 2023

Jan 20, 2023

Feb 01, 2023

Jan 19, 2023

Sep 21, 2022

CVS.NB Final Cash Dividend of gross USD 0.55 paid on Nov 01, 2022 going ex on Oct 20, 2022

Oct 21, 2022

Nov 01, 2022

Oct 20, 2022

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

